Pharmacological modulation of SK3 channels
- 30 June 2001
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 40 (7), 879-887
- https://doi.org/10.1016/s0028-3908(01)00028-4
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Neuroprotective effect of low dose riluzole in gerbil model of transient global ischemiaNeuroscience Letters, 2000
- Pharmacological characterization of small‐conductance Ca2+‐activated K+ channels stably expressed in HEK 293 cellsBritish Journal of Pharmacology, 2000
- The pharmacology of hSK1 Ca2+‐activated K+ channels expressed in mammalian cell linesBritish Journal of Pharmacology, 2000
- Activation of the human intermediate-conductance Ca2+-activated K+ channel by 1-ethyl-2-benzimidazolinone is strongly Ca2+-dependentBiochimica et Biophysica Acta (BBA) - Biomembranes, 1999
- Riluzole prevents ischemic spinal cord injury caused by aortic crossclampingThe Journal of Thoracic and Cardiovascular Surgery, 1999
- Stable expression of the human large‐conductance Ca2+‐activated K+ channel α‐ and β‐subunits in HEK293 cellsFEBS Letters, 1997
- The pharmacology and mechanism of action of riluzoleNeurology, 1996
- Small-Conductance, Calcium-Activated Potassium Channels from Mammalian BrainScience, 1996
- A Controlled Trial of Riluzole in Amyotrophic Lateral SclerosisNew England Journal of Medicine, 1994
- Riluzole specifically blocks inactivated Na channels in myelinated nerve fibrePflügers Archiv - European Journal of Physiology, 1991